Literature DB >> 34814103

Association between Hypertriglyceridemia and Disease Severity in Visceral Leishmaniasis.

Mariana Garcez Varela1,2,3, Mariana de Oliveira Bezerra1, Felipe Vieira Santana1, Marcos Couto Gomes1, Pedro Ribeiro de Jesus Almeida4, Geydson Silveira da Cruz3,5, Enaldo Vieira de Melo6, Paulo Roberto de Oliveira Costa7, Fabrícia Alvisi de Oliveira1, Amélia Ribeiro de Jesus1,3,8, Roque Pacheco de Almeida1,3,8.   

Abstract

Visceral leishmaniasis (VL) is a tropical disease endemic to Brazil. The clinical manifestations of the infection range from asymptomatic to severe. In VL, changes in lipid metabolism, such as hypocholesterolemia and hypertriglyceridemia, occur that are believed to be related to its progression and severity. This study investigated the associations between serum levels of cholesterol, triglycerides, and lipoproteins (high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein) with clinical and hematological parameters that predict severity in a case series of 83 VL patients. Severely ill patients had higher mean serum triglyceride levels than non-severely ill patients. There was a significant positive correlation between disease severity score and serum triglyceride levels, very low-density lipoprotein, international normalized ratio for prothrombin time test, total bilirubin, and age. An inverse correlation was detected between the disease severity score and mean platelet and neutrophil counts. Hypertriglyceridemia can be a prognostic indicator of severity in patients diagnosed with VL.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34814103      PMCID: PMC8832909          DOI: 10.4269/ajtmh.21-0260

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis.

Authors:  Chandra S Lal; Anil Kumar; Sanjay Kumar; Krishna Pandey; Nawin Kumar; Sanjiva Bimal; Prabhat K Sinha; Pradeep Das
Journal:  Clin Chim Acta       Date:  2007-04-19       Impact factor: 3.786

2.  Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis.

Authors:  Evagellos Liberopoulos; George Alexandridis; Eleni Bairaktari; Moses Elisaf
Journal:  Ann Clin Lab Sci       Date:  2002       Impact factor: 1.256

3.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

4.  Diet-induced obesity promotes systemic inflammation and increased susceptibility to murine visceral leishmaniasis.

Authors:  Glênia Daros Sarnáglia; Luciana Polaco Covre; Fausto Edmundo Lima Pereira; Herbert Leonel DE Matos Guedes; Ana Maria Caetano Faria; Reynaldo Dietze; Rodrigo Ribeiro Rodrigues; Tatiani Uceli Maioli; Daniel Cláudio Oliviera Gomes
Journal:  Parasitology       Date:  2016-07-21       Impact factor: 3.234

5.  Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyltransferase and lipase deficiency.

Authors:  B J Auerbach; J S Parks
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

6.  Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil.

Authors:  Wendel Coura-Vital; Valdelaine Etelvina Miranda de Araújo; Ilka Afonso Reis; Frederico Figueiredo Amancio; Alexandre Barbosa Reis; Mariângela Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

7.  Lipid derangement as diagnostic and prognostic indicator for visceral leishmaniasis patients.

Authors:  Sarita Mohapatra; Jyotish C Samantaray; Saroj Dash; Laxshmi Ramakrishan
Journal:  Trop Parasitol       Date:  2014-07

8.  Diabetes Modifies the Clinic Presentation of Cutaneous Leishmaniasis.

Authors:  Alexsandro S Lago; Filipe R Lima; Augusto M Carvalho; Camilla Sampaio; Neuza Lago; Luiz H Guimarães; Jamile Lago; Paulo R L Machado; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  Open Forum Infect Dis       Date:  2020-10-19       Impact factor: 3.835

Review 9.  Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).

Authors:  Yue Zhou; Jingwei Chi; Wenshan Lv; Yangang Wang
Journal:  Diabetes Metab Res Rev       Date:  2020-07-20       Impact factor: 8.128

10.  Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study.

Authors:  Guyi Wang; Quan Zhang; Xianmei Zhao; Haiyun Dong; Chenfang Wu; Fang Wu; Bo Yu; Jianlei Lv; Siye Zhang; Guobao Wu; Shangjie Wu; Xiaolei Wang; Ying Wu; Yanjun Zhong
Journal:  Lipids Health Dis       Date:  2020-09-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.